Article

Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive-08-01-2001
Volume0
Issue 0

Mergers: Big Pharma Shrinks Some

Author(s):

Kevin Gopal

London-GlaxoSmithKline is proposing to cut more than 2,000 jobs from its worldwide workforce of 100,000 as it seeks to generate the promised savings from its merger.

Articles in this issue
chart2-792-1409031554122.jpg
Decision Making at Digital Speed
Mergers: Big Pharma Shrinks Some
Generics: Streamline and Stimulate
pe8_turner_africa-790-1409031558465.jpg
Grace Under Fire
Get Ready to Merge or Diverge
Get Ready to Merge or Diverge
Pharma's Quantum Shuffle

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Pharmaceutical Executive
Helen Sabzevari
Pharmaceutical Executive
Related Content
Stock.adobe.com
September 13th 2025

AbbVie Stock Jumps 4.4% Following Settlement of Litigation with Drug Manufactures Over Rinvoq

Nicholas Jacobus
Pharmaceutical Executive
September 13th 2025

Pharmaceutical Executive Daily: September 12, 2025

Nicholas Jacobus
Stock.adobe.com
September 13th 2025

Novo Nordisk CEO Advocates Employees to Return To Office

Nicholas Jacobus
Pharmaceutical Executive
September 13th 2025

Pharmaceutical Executive Daily: September 11, 2025

Nicholas Jacobus
Stock.adobe.com
September 13th 2025

White House Officials Drafting Executive Order Enforcing Harsh Restrictions on Treatments Discovered in China: Report

Nicholas Jacobus
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
September 13th 2025

FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration

Don Tracy, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.